TrialCancer medicine2024
Cemiplimab monotherapy in Japanese patients with recurrent or metastatic cervical cancer.
Kosei Hasegawa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papertrialcites it
TrialCancer medicine2024
Kosei Hasegawa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.